Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Aclaris Therapeutics, Inc. | Director | Common Stock | 710K | $1.6M | $2.25 | Nov 19, 2024 | Direct |
Merus N.V. | Director | Share Option (right to buy) | 8.84K | $120K | $13.52 | May 7, 2024 | Direct |
Aclaris Therapeutics, Inc. | Director | Restricted Stock Units | 4.79K | $4.94K | $1.03 | Jun 6, 2024 | Direct |
Aclaris Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 15.8K | Jun 6, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ACRS | Aclaris Therapeutics, Inc. | Nov 19, 2024 | 1 | $1.5M | 4 | Nov 20, 2024 | Director |
ACRS | Aclaris Therapeutics, Inc. | Jun 6, 2024 | 2 | $0 | 4 | Jun 10, 2024 | Director |
ACRS | Aclaris Therapeutics, Inc. | Jun 1, 2024 | 2 | $0 | 4 | Jun 4, 2024 | Director |
MRUS | Merus N.V. | May 7, 2024 | 1 | $0 | 4 | May 9, 2024 | Director |
MRUS | Merus N.V. | Jun 8, 2023 | 1 | $0 | 4 | Jun 12, 2023 | Director |
ACRS | Aclaris Therapeutics, Inc. | Jun 1, 2023 | 4 | $0 | 4 | Jun 5, 2023 | Director |
ACRS | Aclaris Therapeutics, Inc. | Jun 2, 2022 | 4 | $0 | 4 | Jun 6, 2022 | Director |
MRUS | Merus N.V. | May 31, 2022 | 1 | $0 | 4 | Jun 2, 2022 | Director |
ACRS | Aclaris Therapeutics, Inc. | Jun 3, 2021 | 2 | $0 | 4 | Jun 4, 2021 | Director |
MRUS | Merus N.V. | May 28, 2021 | 1 | $0 | 4 | Jun 2, 2021 | Director |